Unicycive Therapeutics
UNCY
UNCY
51 hedge funds and large institutions have $65.2M invested in Unicycive Therapeutics in 2026 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
9% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 11
68% less call options, than puts
Call options by funds: $1.13M | Put options by funds: $3.51M
Holders
51
Holding in Top 10
–
Calls
$1.13M
Puts
$3.51M
Top Buyers
| 1 | +$2.52M | |
| 2 | +$1.47M | |
| 3 | +$1.14M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.02M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$937K |
Top Sellers
| 1 | -$819K | |
| 2 | -$319K | |
| 3 | -$303K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$141K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$83.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DB
51
Danske Bank
Copenhagen K,
Denmark
| $7 |
|
|||
52
Squarepoint
New York
| – |
|
|||
|
TRCT
53
Tower Research Capital (TRC)
New York
| – |
|